Day: May 13, 2026

us corporate news

Tyra Biosciences Advances Dabogratinib FGFR3 Clinical Trials, Reports Q1 2026 Financial Results and Milestones

Minichart

May 13, 2026

Tyra Biosciences Reports Q1 2026 Financial Results: Key Adva...

Continue Reading 0

us corporate news

Leatt Corp Announces New $419,410 Share Repurchase Program to Boost Shareholder Value

Minichart

May 13, 2026

Leatt Corp Announces Share Repurchase Program – Key Details ...

Continue Reading 0

us corporate news

Moleculin Biotech, Inc. Files Form 8-K for May 13, 2026 – Company Details, Stock Info, and Regulatory Disclosures

Minichart

May 13, 2026

Moleculin Biotech Announces Imminent Unblinding of Pivotal M...

Continue Reading 0

us corporate news

Reviva Pharmaceuticals Holdings, Inc. Files Form 8-K with SEC – Company Information and NASDAQ Listing Details

Minichart

May 13, 2026

Reviva Pharmaceuticals Holdings, Inc. Announces Nasdaq Delis...

Continue Reading 0

us corporate news

NOVAGOLD Releases 2025 Sustainability Report Highlighting ESG Performance and Donlin Gold Community Engagement 9

Minichart

May 13, 2026

NOVAGOLD Resources Inc. Releases 2025 Sustainability Report:...

Continue Reading 0

us corporate news

Protara Therapeutics Reports Q1 2026 Results, Advances TARA-002 for Lymphatic Malformations and NMIBC with BLA Planned for 2027

Minichart

May 13, 2026

Protara Therapeutics (Nasdaq: TARA) Announces Q1 2026 Financ...

Continue Reading 0

us corporate news

Xenetic Biosciences Reports Q1 2026 Results: Advances DNase Oncology Platform, Grows Royalty Revenue, and Strengthens Financial Position

Minichart

May 13, 2026

Xenetic Biosciences Reports Q1 2026 Results: Key Advancement...

Continue Reading 0

us corporate news

Spruce Biosciences Reports Q1 2026 Financials, Advances TA-ERT Toward FDA Approval for MPS IIIB, and Strengthens Leadership Team

Minichart

May 13, 2026

Spruce Biosciences Q1 2026 Financial Results & Corporate Upd...

Continue Reading 0

us corporate news

Bloomia Holdings, Inc. Reports Q3 2026 Financial Results: Higher Revenue but Increased Losses Amid Cost Pressures and Rights Offering Success

Minichart

May 13, 2026

Bloomia Holdings, Inc. Q3 2026 Financial Results: Investor A...

Continue Reading 0

us corporate news

Whitehawk Therapeutics Raises $87.5M in Private Placement to Advance Antibody Drug Conjugate Cancer Pipeline

Minichart

May 13, 2026

Whitehawk Therapeutics Announces \$87.5M Private Placement E...

Continue Reading 0